P17H (p.Pro17His) variant of AVPR2 (Vasopressin V2 receptor)
P17H (p.Pro17His) in AVPR2 (Vasopressin V2 receptor) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.29 / 1. The record also includes population frequency data.
P17H (p.Pro17His) variant details
- p.Pro17His
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.288
- CADD 6.33
- PolyPhen-2 0.00
- SIFT 0.54
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available